Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 228.86$. Average daily volumn in 3 months 1.46M. Market cap 71.08B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 250.83$. Total volume : 1.61M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
250.83$
Change
1.49
Volume
1.61M

Previous Close249.34
Open251.81
Day Range249.57-254.30
Bid0.00 x 900
Ask0.00 x 800
Volume1.61M
Average Volume1.46M
Market Cap71.08B
Beta0.63
52 Week Range215.90-277.29
Trailing P/E46.62
Foward P/E18.85
Dividend (Yield %)1.53%
Ex-Dividend Date2022-12-08



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2022 were 18.87B an decrease(-5.26%) over the years 2021 revenue that were of 19.13B. In 2022 the company's total earnings were 1.78B while total earnings in 2021 were 2.09B(-50%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors an... d extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
71.08B
Revenue:
18.87B
Total Assets:
52.93B
Total Cash:
1.01B



News about "Becton, Dickinson and Company"

Those who invested in Becton Dickinson (NYSE:BDX) five years ago are up 21%

Source from : Yahoo Finance - 1 days ago

But more than that, you probably want to see it rise more than the market average. But Becton, Dickinson and Company (NYSE:BDX) has fallen short of that second goal, with a share price rise of 10% ...See details»


are-becton-dickinson-and-companys-nysebdx-fundamentals-good-enough-to-warrant-buying-given-the-stocks-recent-weakness-image

Are Becton, Dickinson and Company's (NYSE:BDX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Source from : YAHOO!Finance - 14 days ago

With its stock down 17% over the past three months, it is easy to disregard Becton Dickinson (NYSE:BDX). But if you ...See details»


wall-street-pummels-becton-dickinson-and-company-bdx-after-recent-earnings-report-image

Wall Street Pummels Becton Dickinson and Company (BDX) After Recent Earnings Report

Source from : newsheater - 2 days ago

Becton Dickinson and Company (NYSE:BDX) went up by 1.55% from its latest closing price compared to the recent 1-year high of $277.29. The companyโ€™s stock price has collected 2.70% of gains in the last ...See details»


an-intrinsic-calculation-for-becton-dickinson-and-company-nysebdx-suggests-its-20-undervalued-image

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 20% Undervalued

Source from : Yahoo - 6 days ago

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Becton, Dickinson ...See details»


Becton, Dickinson and Company (BDX) Q4 2022 Earnings Call Transcript

Source from : Seeking Alpha - 22 days ago

We believe our current pipeline is the most exciting in the history of the company. In addition, we deployed over $2 billion this year towards six tuck-in acquisitions, all of which were allocated ...See details»


Becton Dickinson and Co

Source from : Newsweek - 1 month ago

Becton, Dickinson and Company (BD) is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. Founded in 1897 and headquartered in ...See details»


Becton, Dickinson and Company Q4 Profit Increases, beats estimates

Source from : Business Insider - 22 days ago

(RTTNews) - Becton, Dickinson and Company (BDX) reported earnings for its fourth quarter that increased from last year and beat the Street estimates. The company's bottom line totaled $265 million ...See details»


Becton, Dickinson and Company (NYSE:BDX) Not Flying Under The Radar

Source from : AOL - 25 days ago

Becton, Dickinson and Company's (NYSE:BDX) price-to-earnings (or "P/E") ratio of 33.1x might make it look like a strong sell right now compared to the market in the United States, where around ...See details»


Are Investors Undervaluing Becton, Dickinson and Company (NYSE:BDX) By 26%?

Source from : AOL - 29 days ago

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Becton, Dickinson and Company (NYSE:BDX) as an investment opportunity by taking the forecast future ...See details»


Becton, Dickinson and Company (NYSE:BDX) insiders sold US$1.1m worth of stock, possibly signalling a downtrend

Source from : Yahoo News - 1 month ago

Over the past year, many Becton, Dickinson and Company (NYSE:BDX) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is ...See details»


Becton Dickinson expects fiscal 2023 COVID test sales to drag

Source from : Reuters - 22 days ago

Nov 10 (Reuters) - Becton Dickinson and Co (BDX.N) on Thursday forecast a sharp decline in COVID-19 test sales for fiscal year 2023 as it expects the testing market to shrink next year with ...See details»


We Analyzed the Future Direction of Becton Dickinson and Company (BDX), Here is What We Found

Source from : newsheater - 1 year ago

Becton Dickinson and Company (NYSE:BDX) went up by 4.03% from its latest closing price compared to the recent 1-year high of $277.29. The companyโ€™s stock price has collected 4.70% of gains in the last ...See details»


BD Board Increases Dividend for 51st Consecutive Year

Source from : Business Insider - 22 days ago

FRANKLIN LAKES, N.J., Nov. 10, 2022 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share ...See details»


ROUNDUP: Becton, Dickinson And Co. Q3 Profit Down, But Beats Estimates; Ups 2022 Guidance Above View

Source from : Finanznachrichten - 9 days ago

Becton, Dickinson and Company (BDX) reported a profit for third quarter that decreased from last year but beat the Street estimates. The company's earnings came in at $338 million, or $1.18 per share.See details»